Related references
Note: Only part of the references are listed.The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised, and Expanded
Robert J. Kurman et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
VR23: A Quinoline-Sulfonyl Hybrid Proteasome Inhibitor That Selectively Kills Cancer via Cyclin E-Mediated Centrosome Amplification
Sheetal Pundir et al.
CANCER RESEARCH (2015)
Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours
Oluwole Fadare et al.
PATHOLOGY (2015)
Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling
Ronald L. Chandler et al.
NATURE COMMUNICATIONS (2015)
The Lung-Restricted Marker Napsin A Is Highly Expressed in Clear Cell Carcinomas of the Ovary
Patricia L. Kandalaft et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
The emerging roles of ARID1A in tumor suppression
Ren-Chin Wu et al.
CANCER BIOLOGY & THERAPY (2014)
Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers
Alison M. Karst et al.
CANCER RESEARCH (2014)
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy
Ren-Chin Wu et al.
JOURNAL OF PATHOLOGY (2014)
Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis
Bin Guan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma
Elisabetta Kuhn et al.
MODERN PATHOLOGY (2014)
Napsin A as a marker of clear cell ovarian carcinoma
Ingiridur Skirnisdottir et al.
BMC CANCER (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma
Ayse Ayhan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
Elisabetta Kuhn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
Bin Guan et al.
CANCER RESEARCH (2011)
Value of Integrated Positron Emission Tomography Revised Using a Phantom Study to Evaluate Malignancy Grade of Lung Adenocarcinoma A Multicenter Study
Haruhiko Nakayama et al.
CANCER (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary
Martin Köbel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress
Ken Yamaguchi et al.
CLINICAL CANCER RESEARCH (2008)
Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study
M. Takano et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Amplicon profiles in ovarian serous carcinomas
Kentaro Nakayama et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma
DG Rosen et al.
CANCER (2006)
Clear-cell cancer of the ovary - is it chemosensitive?
S Pather et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Cyclin E deregulation alters the biologic properties of ovarian cancer cells
I Bedrosian et al.
ONCOGENE (2004)
Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression
K Kawamura et al.
CANCER RESEARCH (2004)
Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma
R Cassia et al.
JOURNAL OF PATHOLOGY (2003)
Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
K Keyomarsi et al.
NATURE MEDICINE (2003)
Share Paper
